Mainz Biomed Announces Financial Half Year Results 2023 and Provides Corporate Update - Mainz Biomed (NASDAQ:MYNZ)
ColoAlert® Revenue Increases 108% Year Over Year in the First Six Months of 2023 ColoFuture and eAArly Detect Studies on Track to Report Results in September and in Q4, 2023 BERKELEY, Calif. and MAINZ, Germany,